Your healthcare provider will show you where to inject your medication
Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health. The FDAs decision is largely based on data from the SELECT trial, which included more than 17,000 overweight or obese patients with a baseline age of 45 years old
semaglutide, including their side effects, mechanisms of action, administration, and weight loss benefits
Having provider oversight for these decisions, even through a telehealth platform, is significantly safer than trying to manage dosing independently
If you need electrolytes, check with your healthcare provider first
The main difference between semaglutide and tirzepatide is mechanism